CoChat

Protein- and Calcium-Mediated GLP-1 Secretion: A Narrative Review

Open access

The DOI matches its Crossref record; 149 of the 153 references it cites were found in a registry or an index.

Abstract

Glucagon-like peptide 1 (GLP-1) is an incretin hormone produced in the intestine that is secreted in response to nutrient exposure. GLP-1 potentiates glucose-dependent insulin secretion from the pancreatic β cells and promotes satiety. These important actions on glucose metabolism and appetite have led to widespread interest in GLP-1 receptor agonism. Typically, this involves pharmacological GLP-1 mimetics or targeted inhibition of dipeptidyl peptidase-IV, the enzyme responsible for GLP-1 degradation. However, nutritional strategies provide a widely available, cost-effective alternative to pharmacological strategies for enhancing hormone release. Recent advances in nutritional research have implicated the combined ingestion of protein and calcium with enhanced endogenous GLP-1 release, which is likely due to activation of receptors with high affinity and/or sensitivity for amino acids and calcium. Specifically targeting these receptors could enhance gut hormone secretion, thus providing a new therapeutic option. This narrative review provides an overview of the latest research on protein- and calcium-mediated GLP-1 release with an emphasis on human data, and a perspective on potential mechanisms that link potent GLP-1 release to the co-ingestion of protein and calcium. In light of these recent findings, potential future research directions are also presented.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/advances/nmab078

Cites

149 of 149 references verified0 citation errors · 0 not checkable

Statistics

Figures

FIGURE 1 GLP-1 release in response to phenylalanine and accumulative calcium perfusion. Rat small intestine was perfused with Krebs–Henseleit buffer deplete of calcium ± 10 mM phenylalanine. At 20 min, Ca2+ was reintroduced cumulatively into the perfusate every 15 min over 90 min. The figure depicts the extracellular Ca2+–GLP-1 response relation using AUC for each Ca2+ addition. Student unpaired t tests were used to determine significance between control and phenylalanine: **P < 0.01, ***P < 0.001. GLP-1, glucagon-like peptide 1. Reproduced from reference 34 with permission.
FIGURE 1 GLP-1 release in response to phenylalanine and accumulative calcium perfusion. Rat small intestine was perfused with Krebs–Henseleit buffer deplete of calcium ± 10 mM phenylalanine. At 20 min, Ca2+ was reintroduced cumulatively into the perfusate every 15 min over 90 min. The figure depicts the extracellular Ca2+–GLP-1 response relation using AUC for each Ca2+ addition. Student unpaired t tests were used to determine significance between control and phenylalanine: **P < 0.01, ***P < 0.001. GLP-1, glucagon-like peptide 1. Reproduced from reference 34 with permission.CC BY · PubMed Central
FIGURE 2 The potential putative mechanisms of calcium and protein synergy inducing GLP-1 secretion. Amino acids and peptides are sensed by CaSR (amino acids and peptides) and GPRC6A (amino acids only). The ability of CaSR to bind both peptides and amino acids is dependent on the presence of calcium, whereas GPRC6A also contains a calcium-binding site. This binding leads to 2 downstream signaling pathways involving cAMP (red) and phosphatidylinositol (black), leading to GLP-1 exocytosis. PEPT1 mediates the transport of peptides into the cell and subsequently causes membrane depolarization (potentially leading to calcium influx via L-type Ca2+ channels—blue dashed arrows) and ultimately GLP-1 exocytosis. Amino acids that enter the cell via amino acid transporters, including B˚AT1, and peptides that are broken down, join the amino acid intracellular pool. Intracellular amino acids and peptides transported out of the cell might also be sensed by CaSR localized on the basolateral membrane (black dashed arrows), which similarly triggers the signaling pathways highlighted in red and black. AA, amino acids; B˚AT1, sodium-dependent neutral amino acid transporter; CaSR, extracellular calcium-sensing receptor; DAG, diacylglycerol; Epac2, exchange protein directly activated by cAMP 2; ER, endoplasmic reticulum; GLP-1, glucagon-like peptide 1; GPRC6A, G-protein–coupled receptor class C 6A; IP3, inositol 1,4,5-triphosphate; Pep, peptides; PEPT1, peptide transporter 1; PKA, protein kinase A; PKC, protein kinase C; PLC, phospholipase C; ∆ᴪ, membrane depolarization.
FIGURE 2 The potential putative mechanisms of calcium and protein synergy inducing GLP-1 secretion. Amino acids and peptides are sensed by CaSR (amino acids and peptides) and GPRC6A (amino acids only). The ability of CaSR to bind both peptides and amino acids is dependent on the presence of calcium, whereas GPRC6A also contains a calcium-binding site. This binding leads to 2 downstream signaling pathways involving cAMP (red) and phosphatidylinositol (black), leading to GLP-1 exocytosis. PEPT1 mediates the transport of peptides into the cell and subsequently causes membrane depolarization (potentially leading to calcium influx via L-type Ca2+ channels—blue dashed arrows) and ultimately GLP-1 exocytosis. Amino acids that enter the cell via amino acid transporters, including B˚AT1, and peptides that are broken down, join the amino acid intracellular pool. Intracellular amino acids and peptides transported out of the cell might also be sensed by CaSR localized on the basolateral membrane (black dashed arrows), which similarly triggers the signaling pathways highlighted in red and black. AA, amino acids; B˚AT1, sodium-dependent neutral amino acid transporter; CaSR, extracellular calcium-sensing receptor; DAG, diacylglycerol; Epac2, exchange protein directly activated by cAMP 2; ER, endoplasmic reticulum; GLP-1, glucagon-like peptide 1; GPRC6A, G-protein–coupled receptor class C 6A; IP3, inositol 1,4,5-triphosphate; Pep, peptides; PEPT1, peptide transporter 1; PKA, protein kinase A; PKC, protein kinase C; PLC, phospholipase C; ∆ᴪ, membrane depolarization.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

2 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 149 references

Metadata

Authors
Watkins, J. D., Koumanov, F., & Gonzalez, J. T.
Affiliations
University of Bath (GB)
Corresponding author
Gonzalez, Javier T
Venue
Advances in Nutrition
Publisher
Elsevier BV
Published
2021-11
Volume
12
Issue
6
Pages
2540-2552
ISSN
  • 2156-5376 (ISSN-L)
  • 2161-8313
OpenAlex
W3174124430
Cited by
40
References
153
Citations by year
2026: 11 · 2025: 11 · 2024: 8 · 2023: 5 · 2022: 5
FWCI
0.69
Type
journal article
Language
en
Open access
Licence
Locations
  • Advances in Nutrition (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Pure (University of Bath) (publishedVersion, cc-by)
Funders
  • Arla Foods Ingredients
  • MRC (MR/P002927/1)
  • LucozadeRibena Suntory Ltd
  • Kenniscentrum Suiker & Voeding
  • PepsiCo
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
  • Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
Keywords
glucagon-like peptide-1, GLP-1 secretion, dietary protein, dietary calcium, amino acid receptors, calcium-sensing receptor, gut hormone secretion, incretins, GLP-1 receptor agonists, DPP-4 inhibition, nutritional strategies, glucose-dependent insulin secretion, satiety
MeSH terms
Insulin Secretion, Calcium, Diabetes Mellitus, Type 2, Humans, Insulin-Secreting Cells, Glucagon-Like Peptide 1

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.